Skip to content

Clinical trials

Phase 2 Hypoxia-Ischemia, Brain trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoxia-Ischemia, Brain Phase: Phase 2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Michael Cotten1
New York Medical College1
Pia Wintermark1
ReAlta Life Sciences, Inc.1
Takeda1
University of California, San Diego1
University of California, San Francisco1
University of Utah1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoxia-Ischemia, Brain9
Asphyxia Neonatorum2
Seizures2
Brain Diseases1
Central Nervous System Diseases1
Epilepsies, Myoclonic1
Epilepsy1
Heart Arrest1
Hypoxia, Brain1
Lennox Gastaut Syndrome1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.